Nature Communications (Apr 2022)
Emergence and phenotypic characterization of the global SARS-CoV-2 C.1.2 lineage
- Cathrine Scheepers,
- Josie Everatt,
- Daniel G. Amoako,
- Houriiyah Tegally,
- Constantinos Kurt Wibmer,
- Anele Mnguni,
- Arshad Ismail,
- Boitshoko Mahlangu,
- Bronwen E. Lambson,
- Darren P. Martin,
- Eduan Wilkinson,
- James Emmanuel San,
- Jennifer Giandhari,
- Nelia Manamela,
- Noxolo Ntuli,
- Prudence Kgagudi,
- Sandile Cele,
- Simone I. Richardson,
- Sureshnee Pillay,
- Thabo Mohale,
- Upasana Ramphal,
- Yeshnee Naidoo,
- Zamantungwa T. Khumalo,
- Gaurav Kwatra,
- Glenda Gray,
- Linda-Gail Bekker,
- Shabir A. Madhi,
- Vicky Baillie,
- Wesley C. Van Voorhis,
- Florette K. Treurnicht,
- Marietjie Venter,
- Koleka Mlisana,
- Nicole Wolter,
- Alex Sigal,
- Carolyn Williamson,
- Nei-yuan Hsiao,
- Nokukhanya Msomi,
- Tongai Maponga,
- Wolfgang Preiser,
- Zinhle Makatini,
- Richard Lessells,
- Penny L. Moore,
- Tulio de Oliveira,
- Anne von Gottberg,
- Jinal N. Bhiman
Affiliations
- Cathrine Scheepers
- National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS)
- Josie Everatt
- National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS)
- Daniel G. Amoako
- National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS)
- Houriiyah Tegally
- KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal
- Constantinos Kurt Wibmer
- National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS)
- Anele Mnguni
- National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS)
- Arshad Ismail
- National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS)
- Boitshoko Mahlangu
- National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS)
- Bronwen E. Lambson
- National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS)
- Darren P. Martin
- Institute of Infectious Disease and Molecular Medicine, University of Cape Town
- Eduan Wilkinson
- KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal
- James Emmanuel San
- KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal
- Jennifer Giandhari
- KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal
- Nelia Manamela
- National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS)
- Noxolo Ntuli
- National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS)
- Prudence Kgagudi
- National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS)
- Sandile Cele
- Africa Health Research Institute
- Simone I. Richardson
- National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS)
- Sureshnee Pillay
- KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal
- Thabo Mohale
- National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS)
- Upasana Ramphal
- KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal
- Yeshnee Naidoo
- KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal
- Zamantungwa T. Khumalo
- National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS)
- Gaurav Kwatra
- South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
- Glenda Gray
- South African Medical Research Council
- Linda-Gail Bekker
- Desmond Tutu HIV Centre
- Shabir A. Madhi
- South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
- Vicky Baillie
- South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
- Wesley C. Van Voorhis
- Center for Emerging and Re-emerging Infectious Diseases (CERID), University of Washington
- Florette K. Treurnicht
- National Health Laboratory Service (NHLS)
- Marietjie Venter
- Zoonotic Arbo and Respiratory Virus Research Programme, Department of Medical Virology, Faculty of Health, University of Pretoria
- Koleka Mlisana
- School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal
- Nicole Wolter
- National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS)
- Alex Sigal
- Africa Health Research Institute
- Carolyn Williamson
- Institute of Infectious Disease and Molecular Medicine, University of Cape Town
- Nei-yuan Hsiao
- Institute of Infectious Disease and Molecular Medicine, University of Cape Town
- Nokukhanya Msomi
- National Health Laboratory Service (NHLS)
- Tongai Maponga
- Division of Medical Virology, Faculty of Medicine and Health Sciences, Stellenbosch University
- Wolfgang Preiser
- National Health Laboratory Service (NHLS)
- Zinhle Makatini
- National Health Laboratory Service (NHLS)
- Richard Lessells
- KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal
- Penny L. Moore
- National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS)
- Tulio de Oliveira
- KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal
- Anne von Gottberg
- National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS)
- Jinal N. Bhiman
- National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS)
- DOI
- https://doi.org/10.1038/s41467-022-29579-9
- Journal volume & issue
-
Vol. 13,
no. 1
pp. 1 – 9
Abstract
The SARS-CoV-2 PANGO lineage C.1.2 has been under monitoring by global health authorities as it has spread worldwide. Here, Bhiman and colleagues characterise the emergence of the lineage, and its neutralisation sensitivity using data from vaccinees and previously infected individuals.
